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Abstract
Objective—To identify factors associated with antiretroviral therapy (ART) attrition among 
patients initiating therapy in 2005–2011 at two large, public-sector department-level hospitals, and 
to inform interventions to improve ART retention.
Methods—This retrospective cohort study used data from the iSanté electronic medical record 
(EMR) system. The study characterized ART attrition levels and explored the patient 
demographic, clinical, temporal, and service utilization factors associated with ART attrition, 
using time-to-event analysis methods.
Results—Among the 2 023 patients in the study, ART attrition on average was 17.0 per 100 
person-years (95% confidence interval (CI): 15.8–18.3). In adjusted analyses, risk of ART attrition 
was up to 89% higher for patients living in distant communes compared to patients living in the 
same commune as the hospital (hazard ratio: 1.89, 95%CI: 1.54–2.33; P < 0.001). Hospital site, 
earlier year of ART start, spending less time enrolled in HIV care prior to ART initiation, 
receiving a non-standard ART regimen, lacking counseling prior to ART initiation, and having a 
higher body mass index were also associated with attrition risk.
Conclusions—The findings suggest quality improvement interventions at the two hospitals, 
including: enhanced retention support and transportation subsidies for patients accessing care from 
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remote areas; counseling for all patients prior to ART initiation; timely outreach to patients who 
miss ART pick-ups; “bridging services” for patients transferring care to alternative facilities; 
routine screening for anticipated interruptions in future ART pick-ups; and medical case review 
for patients placed on non-standard ART regimens. The findings are also relevant for 
policymaking on decentralization of ART services in Haiti.
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Haiti has the most extensive epidemic of human immunodeficiency virus (HIV) in the 
Caribbean region, with a national adult HIV prevalence rate of 2.2% (1). In the early 2000s, 
several small-scale programs in Haiti demonstrated success in treating HIV-positive patients 
with antiretroviral therapy (ART), inspiring rapid scale-up of ART programs within Haiti 
and globally (2). By the end of 2011, a total of 34 927 Haitians were receiving ART, 
representing approximately 60% of the adults and children requiring therapy (3). Retention 
of ART patients is critical to the program’s success at both the individual and population 
levels.
Since 2004, the Ministry of Public Health and Population (MSPP) in Haiti has maintained an 
electronic medical record (EMR) system called iSanté that contains longitudinal health 
records for patients living with HIV (4). A concerning level of ART attrition is evident in 
iSanté data, with approximately 25% of ART patients recorded as officially discontinued. 
The earthquake of January 2010, which devastated the already-fragile health services 
infrastructure in Port-au-Prince and its surroundings, may have exacerbated ART attrition. 
Prior studies have examined ART attrition in patient cohorts in Port-au-Prince prior to the 
earthquake (5–7), but their findings do not necessarily reflect ART outcomes in other parts 
of Haiti or outcomes during the post-earthquake period.
The objectives of this retrospective cohort study were to identify factors associated with 
ART attrition among patients initiating therapy in 2005–2011 at two large, public-sector 
department-level hospitals and to inform interventions to improve ART retention at these 
sites. Note that in Haiti “departments” are the first and largest sub-national administrative 
level.
MATERIALS AND METHODS
Study setting and patient population
The study cohort included ART patients at Hôpital St. Michel (HSM) in Jacmel (South East 
Department) and Hôpital St. Antoine (HSA) in Jérémie (Grande-Anse Department), sites 
where study authors are engaged in on-going work in health systems strengthening. Both 
sites are the leading secondary hospitals in their respective departments, which are rural and 
mountainous. Both departments are relatively poor: in the Grande-Anse Department, half of 
the population is estimated to fall in the lowest quintile of wealth for Haiti, compared to 
31% in the South East Department (1). The commune (the third administrative level in 
Haiti) of Jacmel, where HSM is located, is 444 km2, while the commune of Jérémie, where 
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HSA is located, is 427 km2. The 2010 earthquake was centered < 30 km from HSM; it 
destroyed several buildings on the hospital campus and killed approximately 300–500 
people in the town of Jacmel (8). In contrast, HSA is located > 150 km from the earth-quake 
epicenter and did not experience direct damage.
The study cohort included patients who were 15 years of age or older at the time of HIV 
program registration, and who started a multidrug ART regimen. The study excluded several 
two-drug ART in women, regimens that were presumed to represent time-limited therapies 
for preventing mother-to-child HIV transmission (PMTCT) under prevailing treatment 
guidelines.
Data source
All study data came from the consolidated server of the iSanté EMR system. iSanté is one of 
three EMR in Haiti, and was used by 71 HIV care and treatment sites covering 
approximately 70% of all ART patients in Haiti in 2011 (9). Data are typically captured on 
standard paper-based iSanté patient encounter forms, and then retrospectively entered into 
the system. In addition to capturing data within an EMR, sites are required to keep paper-
based registers with summary data on all ART patients. iSanté data extracts were obtained 
on 1 February 2012. The average lag-time for electronic data entry is < 1 week, meaning 
that the data extract was an up-to-date representation for the cohort. Data cleaning involved 
inspection and adjudication of elements that violated field validation rules or plausible data 
relationships. Elements that could not be adjudicated or that were determined to be errors 
were coded as missing.
Outcome variable
The outcome variable was time in days from ART start to attrition. ART start date was 
defined as the first dispense date for the multi-drug ART regimen. A variety of definitions of 
ART attrition have been used in international research (5, 10–12). The primary definition of 
attrition was the failure to return for pharmacy pick-up within 30 days of the expected ART 
refill date (“30+ day pharmacy definition”). In sensitivity analyses, three alternative 
definitions were considered: (a) no return pharmacy pick-up within 60 days (“60+ day 
pharmacy definition”); (b) no return for any type of outpatient HIV visit within 90 days 
(“90+ day encounter definition”), the MSPP standard definition; and (c) no return for any 
type of outpatient HIV visit within 180 days (“180+ day encounter definition”), a proposed 
universal definition suggested by empirical findings on loss-to-follow-up (LTFU) among 
more than 180 000 patients in 19 countries (10).
To calculate ART attrition from pharmacy data, ART refill due dates were defined for every 
interval between pharmacy visits, based on dispense dates and number of dose-days 
dispensed. Missing dispense dates (missing in 4.1% of pharmacy records) were imputed 
using the date of the clinical visit where the prescription was made (concordant in 97.8% of 
cases where both dates were available). The minimum number of dose-days dispensed for 
any single medication within a regimen was used to calculate the refill due date for the 
overall regimen. Missing dose-days dispensed (missing in 3.9% of pharmacy records) were 
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imputed using the patient-specific median dose-days or, if this was unavailable, the median 
dose-days for the study cohort.
A patient was counted as a case of attrition upon the first incident of failure to return in a 
timely manner. To partially account for patient transfers within the network of iSanté sites, a 
matching algorithm was used to identify those who presented for care at another iSanté site 
before the pharmacy refill or encounter due date. These patients were then counted as 
transfer cases rather than ART attrition cases, and their observations were censored as of the 
due date. Transfers of care to facilities outside of the iSanté data system could not be 
verified.
Haiti lacks a national death registry for ascertainment of mortality, and both hospitals lack 
resources for tracing patients who failed to return, meaning that official ART disenrollment 
forms citing a reason for discontinuation were only available for a small fraction. For these 
reasons, deaths could not be distinguished from cases of LTFU. In sum, the outcome 
measure represented a composite of several possible reasons for attrition, with accounting 
for patient transfers to other iSanté network facilities.
Covariates
Factors assessed for association with ART attrition were: temporal factors, patient 
demographic factors, patient clinical factors, and service utilization factors (Figure 1). 
Cluster of differentiation 4 cells (CD4), body mass index (BMI), disease stage by World 
Health Organization (WHO) guidelines, tuberculosis (TB) status, and presence of symptoms 
associated with WHO Stage IV were entered into analytic models as baseline covariates, 
measured during a baseline period of 180 days prior to ART initiation. TB status was a 
binary variable indicating a confirmed TB diagnosis, use of TB prophylaxis, or suspicion of 
TB during the baseline period. ART regimen was the initial regimen prescribed. Proximity 
of patient residence to the hospital used the commune of residence at initial registration in 
HIV care, and defined categories of residing in the same, adjacent, or non-adjacent (more 
distant) commune as the hospital.
Statistical methods
This study used time-to-event analysis methods (13). Observations of patient outcomes were 
censored for transfer cases or for patients not meeting the attrition definition as of 1 January 
2012. Descriptive statistics were used to characterize the sample and identify the number of 
patients meeting the primary and alternative ART attrition definitions. The Kaplan-Meier 
method was used to estimate average rates of attrition, attrition levels at specific time points, 
and attrition levels by patient sub-groups. Unadjusted and adjusted semi-parametric Cox 
regression models were used to obtain hazard ratio (HR) estimates for observed covariates. 
The adjusted model included a post-earthquake indicator as a time-varying exposure to 
allow for different attrition risk before and after the earthquake. To test for a differential 
earthquake effect by site, an interaction term for hospital site and the post-earthquake period 
was also included. To avoid assumptions of linearity in relationships, baseline BMI and 
baseline CD4 were classified as categorical variables with logical or clinically-relevant cut-
points (see Table 1 for cut-points).
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To handle missing data on the covariates proximity of residence (< 1% missing), WHO 
Stage (3.0 % missing), BMI (7.7% missing), and CD4 (17.0% missing), multiple imputation 
using chained equations were employed. This method has been shown to minimize bias in 
risk estimates relative to other possible methods for handling missing covariate data (14–
16). The imputation model included all model variables; five imputed datasets were created 
(17). Categorical variable constructs were tested with joint testing of coefficients. To assess 
the sensitivity of the study findings to this strategy for handling missing data, the analyses 
compared models using complete case analysis, missing indicator dummy variables for 
covariates with missing data, and manual imputation using extreme values, for each of the 
attrition definitions. All analyses were performed using Stata®/MP12 (StataCorp LP, 
College Station, Texas, United States).
Ethical review
The study protocol was reviewed and approved by the University of Washington (Seattle, 
Washington, United States), the Haiti National Bioethics Committee (Port-au-Prince, Haiti), 
and the United States Centers for Disease Control and Prevention (Atlanta, Georgia, United 
States). The study used only de-identified patient data.
RESULTS
The study cohort included 2 023 patients who had received a multidrug ART regimen at the 
two hospital sites by the end of 2011. The cohort excluded 113 pediatric patients, 15 patients 
of unknown age or year of birth, and 1 patient of unknown gender. Characteristics of the 
patient population are shown in Table 1. Overall, 694 patients (34.3%) met the 30+ day 
pharmacy attrition definition; 331 (16.4%) met the 60+ day pharmacy attrition definition; 
966 (47.8%) met the 90+ day encounter definition; and 321 (15.9%) met the 180+ day 
encounter definition. Only a small number of patients who stopped receiving care at the two 
sites made timely transfers to an alternative facility (1 timely transfer under the 30+ day 
pharmacy definition, and 4 timely transfers under the alternative definitions).
Under all definitions, attrition rose steeply during the first 12 months after ART initiation, 
with 26.6% of patients abandoning ART under the 30+ day pharmacy definition (95% 
confidence interval [95%CI]: 24.6%–28.7% (Figure 2). While attrition under the 30+ day 
pharmacy definition tapered considerably after 12 months, it increased more steadily over 
time under the 90+ day encounter definition (Figure 2). Attrition under the 60+ day 
pharmacy definition was about half of that under the 30+ day pharmacy definition at each 
time point. This indicates that a sizable proportion of attrition reflected temporary 
interruptions in care. Attrition under the 60+ day pharmacy definition and the 180+ 
encounter definition was similar. ART attrition was notably higher at HSA in Jérémie than 
at HSM in Jacmel, for every definition and for every time point (Figure 2).
Rates of attrition per 100 person-years by patient subgroups are shown in Table 1, based on 
the 30+ day pharmacy definition. In unadjusted analyses, factors associated with attrition 
were: hospital site at HSA (P < 0.001); location of residence (P < 0.001); ART start year (P 
< 0.001); baseline CD4 (P < 0.001); ART regimen (P = 0.03); not having a WHO Stage IV 
symptom reported (P = 0.01); and pre-ART duration (P < 0.01). There were no meaningful 
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differences in rates of attrition by gender, age, BMI, WHO Stage, TB status, and number of 
counseling sessions prior to ART initiation, in unadjusted analyses.
In the adjusted analysis, there was no evidence that the relative risk of attrition between the 
two hospitals changed following the 2010 earthquake (P = 0.66 for interaction term). The 
results of the main-effects adjusted Cox model are presented in Table 2. After adjustment for 
all covariates, the following were strongly associated with ART attrition: proximity of 
residence, hospital site, and year of ART start (representing a cohort effect by calendar 
year). Adjusted ART attrition risk was 69% higher for patients residing in an adjacent 
commune (Hazard ratio [HR]: 1.69, 95%CI: 1.39–2.06; P < 0.001) and 89% higher for 
patients residing in a non-adjacent commune (HR: 1.89, 95%CI: 1.54–2.33; P < 0.001), 
compared to patients residing in the same commune as the hospital. Adjusted ART attrition 
risk was meaningfully lower at HSM in Jacmel versus at HSA in Jérémie, both before and 
after the earthquake (HR: 0.58, 95%CI: 0.49–0.70; P < 0.001). The adjusted model showed 
a risk of attrition that decreased successively with calendar time of ART start (P < 0.001), 
but there was no evidence of a specific temporal effect related to the earth-quake (HR: 0.94 
for post-earthquake compared to pre-earthquake, 95%CI: 0.73–1.22; P = 0.66). Having 
shorter duration of enrollment in HIV care prior to ART initiation (P < 0.01), having a non-
standard ART regimen (P < 0.05), having no counseling sessions prior to ART initiation (P 
< 0.10), and having a BMI > 18.5 (P < 0.10) were also associated with higher attrition risk 
in the adjusted analysis.
The findings of elevated attrition risk by distance of patient residence and by hospital site 
were robust across sensitivity analyses using alternative attrition definitions and alternative 
strategies for handling missing data (Table 3). The findings on attrition risk by calendar 
period, ART regimen, and number of counseling sessions prior to ART initiation were more 
sensitive to the attrition definition and to the strategy for handling missing data. Calendar 
period was significantly associated with attrition risk in all models except the model using 
the 60+ day pharmacy definition; however, ART regimen and number of counseling 
sessions were not significantly associated factors in the sensitivity analyses.
DISCUSSION
This study describes ART attrition before and after the 2010 earthquake in two large public-
sector hospitals in rural departments of Haiti. The detailed, routine pharmacy data in iSanté 
enables measurement of attrition via the 30+ day pharmacy definition, an outcome measure 
that reflects continuity of actual ART use, and that is sensitive to any interruptions of 
clinical significance. Our exploratory findings point to several quality improvement 
interventions with potential to improve ART program outcomes at both hospitals.
That ART attrition risk was sharply higher at HSA in Jérémie compared to HSM in Jacmel, 
a finding that is consistent with other studies from Haiti showing the heterogeneity of ART 
attrition in different facilities and geographic areas (5, 9, 18). For example, unpublished 
studies by the MSPP found that in 2010, ART attrition after 12 months ranged from 13%–
48% among facilities with at least 50 ART patients (9); and ranged from 6%–51% by 
department among ART enrollees in 2007, 2010, and 2011 (18). The relatively high rate of 
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ART attrition observed at HSA may reflect the relative disadvantage of the GrandAnse 
Department (1).
The finding of elevated risk of attrition for patients residing at a greater distance from the 
hospital was noteworthy. Since the start of the national ART program, Haiti has steadily 
decentralized ART to bring services closer to the people in need, growing the number of 
ART sites from two in 2003 to more than 63 in 2011 (3, 9). However, as late as 2011, 36% 
of patients newly enrolling in ART at HSA and HSM still resided outside the commune of 
the hospital. This finding is consistent with evidence from other low-resource settings where 
patient travel distance and transportation barriers play a role in ART attrition (19). Studies in 
Malawi, South Africa, and Mozambique have all demonstrated more favorable ART 
retention in decentralized primary care centers compared with larger centralized hospitals 
(12, 20, 21). We can presume that travel distance plays a strong role in explaining these 
findings.
In Haiti, as in other countries, the question of the right level of ART decentralization is 
complex. There is tension between the goal of increasing patient access to ART via 
decentralization, and the goal of maintaining quality of care via concentration of resources 
in larger, regionalized care centers. Within the global health services literature, there is a 
compelling body of evidence indicating that greater patient volume is associated with 
improved health outcomes in HIV care (22–24), as well as other areas such as surgery (25), 
cardiac care (26), and neonatal care (27). Patients, who travel long distances for ART 
services, whether by necessity or preference, need supportive services to counteract elevated 
risk of attrition, particularly considering the limited resources available for continued ART 
decentralization in Haiti.
The pattern of decreased attrition risk with maturation of the national ART program is 
consistent with evidence from other low-resource countries (5, 11, 12, 28, 29), likely 
reflecting greater provider experience and access to medical technologies over time. ART 
attrition did not increase following Haiti’s devastating earthquake of 2010 at either site, 
which reflects tremendous public health efforts to rapidly re-establish ART services 
following the earthquake (30).
Our finding that adjusted attrition risk was 26% lower for patients receiving two or more 
counseling sessions before ART initiation compared to those who did not receive counseling 
differ from that of a Ugandan study reporting no benefit from counseling sessions (31). In 
the Haitian context, counseling sessions may effectively identify and mitigate some barriers 
to care.
Quality improvement interventions
Together, our findings suggest several interventions to improve retention of patients on 
ART. First, targeting patients who access care from remote areas (non-adjacent communes) 
with enhanced retention support by community health workers may be fruitful. Mobilizing 
greater material resources for transportation subsidies may also be important. Offering 
counseling for all patients prior to ART initiation could help ensure that patients’ access 
barriers are more universally and systematically identified. Scheduling outreach to patients 
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who are late for ART refills based on automated alerts arising from ART dispensing data, 
without waiting until 90 days elapse between visits, could also mitigate attrition. Providing 
“bridging services” whereby community health workers accompany transferring patients to 
the new facility in a timely manner could also help ensure that ART use remains 
uninterrupted during the transfer process. Routine screening at each ART pick-up for 
anticipated inability to return in a timely manner for the next refill, possibly due to 
upcoming travel, would allow providers to adjust the duration of ART dispenses 
accordingly. Finally, conducting medical case review for patients placed on non-standard 
ART regimens could help improve ART outcomes for these patients. Of course, the 
associations observed in this study cannot be interpreted as causal, due to the possibility that 
unmeasured patient characteristics drive the observed relationships. Still, the suggested 
quality improvement interventions are worthy of further testing at the two hospitals.
Study limitations
Data quality within routine health information systems in low-resource settings, such as 
iSanté, is typically considered to be weak (32). However, a data validation exercise 
comparing iSanté electronic data with data from paper charts and ART registers within a 
randomly selected sample of 200 ART patients from the two hospitals, found a high 
concordance (≥ 90%) of both outcome and covariate data between sources for patient 
demographic data, weight, CD4, and ART medication prescriptions (33). Further, our 
estimates of attrition closely matched estimates independently obtained by the MSPP from 
paper-based ART registers at each of the two sites, for the cohort of patients enrolled on 
ART in 2010 (9). In sum, the consistency of both outcomes and covariate data between 
iSanté and other data sources underscores that the iSanté data were fit for use for this study.
The lack of cause-specific information about attrition represents a second limitation. Our 
estimates of absolute attrition levels may be upwardly biased due to our inability to fully 
account for transfers of care to sites outside of the iSanté network. However, given that 
iSanté sites account for more than half of patients enrolled in the national ART program, the 
number of uncounted transfer cases in our cohort was likely small. This means that neither 
the absolute attrition estimates nor the hazard ratio estimates are likely to be strongly 
affected by missing information about patient transfers.
The absence of socioeconomic data on income, occupation, and education is an important 
limitation of the iSanté data system, as is its lack of data on other influential patient and 
system-level factors, namely, mental health status, provider experience level, availability 
and use of ancillary services such as nutrition support, and history of ART stock-outs 
(Figure 1). Still, iSanté represents a remarkably rich data source for operational research and 
monitoring of quality improvement interventions.
Conclusions
ART attrition differed notably between the two hospitals and was strongly associated with 
distance of patient residence from the facility. The latter finding has important policy 
implications with respect to decentralization of services and argues for minimizing 
transportation-related access barriers. As Haiti expands its criteria for ART eligibility, 
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challenges of maximizing retention will intensify. Quality improvement interventions that 
target retention support to patients residing in remote areas, and that promptly provide 
outreach to patients who miss ART refills, merit testing at the two facilities, as well as at 
other similar facilities in Haiti. This study demonstrates the potential of the iSanté system to 
not only inform the design of interventions for improved ART retention, but also to monitor 
and evaluate their success over time.
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FIGURE 1. Conceptual model for HIV antiretroviral therapy (ART) attrition at two hospitals in 
Haiti, 2005–2011
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FIGURE 2. Antiretroviral therapy (ART) attrition estimates at two hospitals in Haiti, 2005–2011
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TABLE 1
Patient characteristics and rates of antiretroviral therapy (ART) attrition at two hospitals in Haiti, 2005–2011
Patients Attrition a
Rate per
100 person-years
95% CI
Characteristic No. % No. Lower Upper P valueb
Overall 2 023 100 694 17.0 (15.8, 18.3)
Hospital sites
 Hôpital St. Antoine in Jérémie 1 052 52 434 21.5 (19.6, 23.6)
 Hôpital St. Michel in Jacmel 971 48 260 12.6 (11.1, 14.2) < 0.001
Gender
 Male 877 43 295 16.2 (14.5, 18.2)
 Female (not pregnant) 1 043 52 367 17.5 (15.8, 19.4)
 Female (pregnant) 103 5 32 19.2 (13.6, 27.1) 0.83
Age group (years)
 < 25 182 9 62 17.2 (13.4, 22.1)
 25–44 1 254 62 428 16.6 (15.1, 18.3)
 ≥ 45 587 29 204 17.8 (15.5, 20.4) 0.87
Residence
 Same commune 1 301 64 389 13.4 (12.1, 14.8)
 Adjacent commune 419 21 158 20.8 (17.8, 24.3)
 Non-adjacent commune 291 14 140 34.0 (28.8, 40.1)
 Missing 12 1 7 60.9 (29.1, 127.8) < 0.001
Body mass index
 ≤ 18.5 529 26 180 16.2 (14.0, 18.7)
 > 18.5 1 338 66 471 17.4 (15.9, 19.1)
 Missing 156 8 43 15.9 (11.8, 21.4) 0.63
ART start
 2005–2006 343 17 192 18.1 (15.7, 20.8)
 2007–2008 645 32 261 14.6 (12.9, 16.4)
 2009–2010 660 33 208 19.8 (17.3, 22.7)
 2011 375 19 33 18.3 (13.0, 25.8) < 0.001
Baseline CD4
 < 100 485 24 164 14.8 (12.7, 17.2)
 100–249 743 37 253 15.9 (14.0, 18.0)
 250+ 453 22 129 18.4 (15.5, 21.9)
 Missing 342 17 148 21.8 (18.6, 25.6) < 0.001
ART regimenc
 AZT-3TC-EFV 1 122 55 371 16.4 (14.8, 18.2)
 AZT-3TC-NVP 690 34 268 18.7 (16.6, 21.1)
 d4T-3TC-EFV or TDF-3TC-EFV 88 4 18 9.8 (6.2, 15.5)
 d4T-3TC-NVP or TDF-3TC-NVP 89 4 24 13.7 (9.2, 20.5)
 Non-standard 34 2 13 36.6 (21.2, 63.0) 0.03
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Patients Attrition a
Rate per
100 person-years
95% CI
Characteristic No. % No. Lower Upper P valueb
World Health Organization clinical stage
 Stage I or II 1 187 59 387 16.4 (14.8, 18.1)
 Stage III or IV 776 38 280 17.4 (15.4, 19.5)
 Missing 60 3 27 25.7 (17.6, 37.4) 0.05
Tuberculosis status
 No 1 581 78 530 17.7 (16.3, 19.3)
 Yes 442 22 164 15.0 (12.8, 17.4) 0.96
Stage 4 symptom
 No 1 728 85 630 17.1 (15.8, 18.5)
 Yes 295 15 64 15.9 (12.5, 20.3) 0.01
Pre-ART duration (months)
 < 1 677 33 255 20.8 (18.4, 23.6)
 1–6 689 34 239 15.9 (14.0, 18.0)
 > 6 657 32 200 14.7 (12.8, 16.9) < 0.01
Counseling sessions
 0 1 332 66 481 16.9 (15.4, 18.4)
 1 539 27 166 17.5 (15.0, 20.4)
 ≥ 2 152 8 47 16.6 (12.5, 22.1) 0.35
aART attrition is defined as being 30 or more days late for an ART pharmacy re-fill (“30+ day pharmacy definition”).
b
P value based upon log-rank test of equality of survivor functions.
cART regimen: AZT = zidovudine; 3TC = lamivudine; EFV = efavirenz; NVP = nevirapine; d4T = stavudine; TDF = tenofovir.
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TABLE 2
Adjusted hazard ratios for antiretroviral therapy (ART) attrition at two hospitals in Haiti, 2005–2011a
Risk factor
Hazard
ratio
95% confidence
interval P value
Sites
 Hôpital St. Michel in Jacmel vs. Hôpital St. Antoine in
  Jérémie 0.58 (0.49, 0.70) < 0.001
 Post- vs. pre-earthquake 0.94 (0.73, 1.22) 0.66
Gender (male = reference)
 Female (not pregnant) 0.99 (0.81, 1.21) 0.92
 Female (pregnant) 1.08 (0.72, 1.62) 0.71
Age (10 years or more) 1.05 (0.97, 1.13) 0.20
Proximity (same commune = reference)b
 Adjacent commune 1.69 (1.39, 2.06) < 0.001
 Non-adjacent commune 1.89 (1.54, 2.33) < 0.001
Body mass index (< 18.5 = reference)
 >18.5 1.19 (0.99, 1.42) 0.06
Year of ART start (2005–2006 = reference)b
 2007–2008 0.66 (0.54, 0.81) < 0.001
 2009–2010 0.60 (0.44, 0.81) 0.001
 2011 0.37 (0.23, 0.61) < 0.001
Baseline CD4 (< 100=reference)
 100–249 1.06 (0.86, 1.30) 0.58
 ≥ 250 1.15 (0.86, 1.54) 0.33
ART regimenc (AZT-3TC-EFV=reference)d
 AZT-3TC-NVP 1.14 (0.92, 1.42) 0.23
 d4T or TDF + 3TC-EFV 0.67 (0.42, 1.08) 0.10
 d4T or TDF + 3TC-NVP 0.86 (0.55, 1.34) 0.51
 non-standard regimens 2.04 (1.16, 3.59) 0.01
World Health Organization clinical stage
 (Stage I or II = reference)
 Stage III or IV 1.16 (0.99, 1.37) 0.07
Tuberculosis status (No suspicion, prophylaxis or
 diagnosis = reference)
 Yes 0.91 (0.74, 1.10) 0.32
Any Stage IV symptom (No = reference)
 Yes 0.84 (0.64, 1.11) 0.22
Pre-ART duration (30 day increase) 0.99 (0.98, 1.00) 0.01
Counseling sessions prior to ART start (None = reference)e
 1 0.84 (0.70, 1.01) 0.07
 ≥ 2 0.74 (0.54, 1.01) 0.06
a
Main effects model using 30+ day pharmacy definition for ART attrition.
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b
P value using joint testing of coefficients: P ≤ 0.001.
cART regimen: AZT = zidovudine; 3TC = lamivudine; EFV = efavirenz; NVP = nevirapine; d4T = stavudine; TDF = tenofovir.
d
P value using joint testing of coefficients: P ≤ 0.05.
e
P value using joint testing of coefficients: P ≤ 0.10.
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TABLE 3
Sensitivity analyses for alternative definitions of antiretroviral therapy (ART) attrition: Adjusted hazard ratios 
(HR), Haiti, 2005–2011a
30+ day pharmacy 60+ day pharmacy 90-day visit 180-day visit
Risk factor HR P value HR P value HR P value HR P value
Site
 Hôpital St. Michel in Jacmel vs.
  Hôpital St. Antoine in Jérémie
0.58 < 0.001 0.53 < 0.001 0.46 < 0.001 0.95 0.69
 Post vs. pre-earthquake 0.94 0.66 0.77 0.14 0.38 < 0.001 0.51 < 0.01
Gender (male=reference)
 Female (not pregnant) 0.99 0.92 1.07 0.67 1.08 0.40 1.02 0.90
 Female (pregnant) 1.08 0.71 1.20 0.54 1.16 0.42 1.44 0.22
Age (10 years or more) 1.05 0.20 0.98 0.75 0.92 0.02 0.84 < 0.01
Proximity (same commune=reference)
 Adjacent commune 1.69 < 0.001 1.44 0.02 1.03 0.77 1.20 0.25
 Non-adjacent commune 1.89 < 0.001 2.37 < 0.001 1.65 < 0.001 2.58 < 0.001
Body mass index (< 18.5=reference)
 >18.5 1.19 0.06 1.18 0.21 1.18 0.04 1.40 0.02
Year of ART start (2005-2006=reference)
 2007–2008 0.66 < 0.001 0.91 0.56 2.02 < 0.001 1.14 0.36
 2009–2010 0.60 < 0.01 1.09 0.71 1.67 < 0.001 0.81 0.41
 2011 0.37 < 0.001 0.54 0.13 2.20 < 0.01 0.88 0.77
Baseline CD4 (< 100=reference)
 100–249 1.06 0.58 1.01 0.97 1.06 0.54 0.75 0.05
 ≥ 250 1.15 0.33 0.98 0.92 1.04 0.74 0.78 0.18
ART regimenb (AZT-3TC-EFV=reference)
 AZT-3TC-NVP 1.14 0.23 0.94 0.70 0.87 0.16 0.79 0.15
 d4T or TDF + 3TC-EFV 0.67 0.10 0.47 0.07 1.01 0.97 1.08 0.81
 d4T or TDF + 3TC-NVP 0.86 0.51 0.78 0.45 0.73 0.09 0.66 0.21
 non-standard regimens 2.04 0.01 1.04 0.94 0.54 0.07 1.17 0.73
World Health Organization clinical stage (Stage
I or II = reference)
 Stage III or IV 1.16 0.07 1.19 0.15 1.11 0.13 1.09 0.51
Tuberculosis status (No suspicion, prophylaxis or
diagnosis = reference)
 Yes 0.91 0.32 0.95 0.75 0.94 0.48 1.03 0.81
Any Stage IV symptom (No=reference)
 Yes 0.84 0.22 0.77 0.21 0.94 0.64 1.16 0.47
Pre-ART duration (30 day increase) 0.99 0.01 0.99 0.07 0.99 < 0.01 0.98 0.01
Counseling sessions prior to ART start (None = reference)
 1 0.84 0.07 0.92 0.52 1.11 0.22 1.05 0.73
 ≥ 2 0.74 0.06 0.83 0.42 0.99 0.93 0.92 0.75
a
Main effects model using alternative definitions for ART attrition; items in bold represent statistically significant hazard ratios.
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bART regimen: AZT = zidovudine; 3TC =l amivudine; EFV = efavirenz; NVP = nevirapine; d4T = stavudine; TDF = tenofovir.
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